Safety limits of antidepressant use plus combinations: focus on cardiovascular function (2018)
Fonte: Current drug metabolism. Unidade: FM
Assuntos: SEROTONINA, DOENÇAS CARDIOVASCULARES, ANTIDEPRESSIVOS, PLACEBOS, INFARTO DO MIOCÁRDIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
STELLA, Florindo et al. Safety limits of antidepressant use plus combinations: focus on cardiovascular function. Current drug metabolism, v. 19, n. 8, p. 641-652, 2018Tradução . . Disponível em: https://doi.org/10.2174/1389200219666171227203225. Acesso em: 13 nov. 2024.APA
Stella, F., Loureiro, J. C., Pais, M. V., Canineu, P. R., & Forlenza, O. V. (2018). Safety limits of antidepressant use plus combinations: focus on cardiovascular function. Current drug metabolism, 19( 8), 641-652. doi:10.2174/1389200219666171227203225NLM
Stella F, Loureiro JC, Pais MV, Canineu PR, Forlenza OV. Safety limits of antidepressant use plus combinations: focus on cardiovascular function [Internet]. Current drug metabolism. 2018 ; 19( 8): 641-652.[citado 2024 nov. 13 ] Available from: https://doi.org/10.2174/1389200219666171227203225Vancouver
Stella F, Loureiro JC, Pais MV, Canineu PR, Forlenza OV. Safety limits of antidepressant use plus combinations: focus on cardiovascular function [Internet]. Current drug metabolism. 2018 ; 19( 8): 641-652.[citado 2024 nov. 13 ] Available from: https://doi.org/10.2174/1389200219666171227203225
